The clinical trial industry struggles with enrollment due to a lack of curiosity and rushed judgments. The "Be Curious" approach is key to addressing enrollment challenges. Questioning and engaging with diverse sites prior to feasibility assessment is crucial. Understanding and addressing site-specific issues can optimize enrollment and study timelines.
Reminiscing about childhood vacations, where everything possible was packed to ensure nothing was lacking. This is not unlike sponsors' approach to clinical trial recruitment & enrollment. While many approaches are utilized, there are a number that remain as significant barriers to enrollment. A thorough overhaul is needed to improve enrollment.
Effective clinical trial recruitment is marred by a lack of prioritization. Despite considerable investments, the pivotal steps often slip through the cracks. Fostering a culture that gives due diligence to connecting suitable candidates with study teams is essential.
Recruitment in clinical trials is in crisis. Most trials don't meet their recruitment targets on time. One reason for this is the industry's short term approach to recruitment. Recruitment is only contemplated one study at a time when it should be approached as a long term plan.
Someday soon, the stickies that CRAs use will be a thing of the past. We'll reminisce about the good old days when the patient's paper clinical research charts were full of stickies... or maybe not.
The FDA finally released its draft guidance on Decentralized Clinical Trials (DCTs). Is it everything we've been waiting for?
"Decentralized clinical trials" is the new buzz phrase in the clinical research community. The advancement of decentralized trials has been accelerated due to the pandemic and the need to do more remotely. As this new era dawns in clinical research, we need to exercise caution before diving headfirst.
Unfortunately, some participants withdraw from clinical trials because they didn't understand what they were getting into. Why does this happen and how can it be avoided?
A patient's perspective on wanting to join a clinical trial, but there are often a lot of barriers in the way.
One strategy to make clinical trials more patient-centric is to work to make them more site-centric.
Clinical Research 